title: PharmGKB summary: very important pharmacogene information for CYP4F2.
authors.affiliation: Departments of aGenetics bBioengineering, Stanford University, Stanford, California, USA.
authors.forename: Maria L
authors.initials: ML
authors.lastname: Alvarellos
authors.forename: Katrin
authors.initials: K
authors.lastname: Sangkuhl
authors.forename: Roxana
authors.initials: R
authors.lastname: Daneshjou
authors.forename: Michelle
authors.initials: M
authors.lastname: Whirl-Carrillo
authors.forename: Russ B
authors.initials: RB
authors.lastname: Altman
authors.forename: Teri E
authors.initials: TE
authors.lastname: Klein
mesh_terms: D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D000072470:Cytochrome P450 Family 4; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000235:genetics / Q000378:metabolism; D007975:Leukotriene B4 / Q000235:genetics / Q000378:metabolism; D010597:Pharmacogenetics; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D006893:Hydroxyeicosatetraenoic Acids; D007975:Leukotriene B4; D014859:Warfarin; C055987:20-hydroxy-5,8,11,14-eicosatetraenoic acid; D003577:Cytochrome P-450 Enzyme System; D000072470:Cytochrome P450 Family 4; C117480:CYP4F2 protein, human